The significance of inclusion morphology and composition in governing hydrogen transportation and trapping in steels

Author(s):  
Zhixian Peng ◽  
Jing Liu ◽  
Feng Huang ◽  
Shiqi Zhang ◽  
Qian Hu ◽  
...  
Keyword(s):  
1994 ◽  
pp. 197-203
Author(s):  
P. Thibault ◽  
D. Bouvard ◽  
P. Stutz ◽  
R. Baccino
Keyword(s):  

1994 ◽  
Vol 128 (3-4) ◽  
pp. 243-258 ◽  
Author(s):  
P.G. Burnard ◽  
F. Stuart ◽  
G. Turner

1998 ◽  
Vol 46 (11) ◽  
pp. 3905-3913 ◽  
Author(s):  
F. Delie ◽  
D. Bouvard

2010 ◽  
Vol 76 (10) ◽  
pp. 1166-1170
Author(s):  
Naoki MATSUI ◽  
Tatsuya HASEGAWA ◽  
Junsuke FUJIWARA

2019 ◽  
Author(s):  
Adil Mohamed ◽  
Derek R. Clements ◽  
Prathyusha Konda ◽  
Shashi A. Gujar ◽  
Patrick W. Lee ◽  
...  

ABSTRACTThe Dearing strain of Mammalian orthoreovirus (T3D) is undergoing clinical trials as an oncolytic virotherapeutic agent. In this study, a comprehensive phenotypic and genetic comparison of T3D virus stocks from various laboratories and commercial sources revealed that T3D laboratory strains differ substantially in their oncolytic activitiesin vitroandin vivo. Superior replication of the most-oncolytic T3D lab strain was attributed to several mechanistic advantages: virus-cell binding, viral RNA transcriptase activity, viral inclusion morphology, and differential activation of RIG-I versus NFκB-dependent signalling pathways. Viral S4, M1 and L3 gene segments were each independently associated with a distinct mechanistic advantage. Furthermore, the specific missense polymorphisms that governed replication potency were identified, and utilized to generate a hybrid of T3D laboratory strains with further-augmented replication in tumor cells. Together, the results depict an elaborate balance between reovirus replication and host-cell signaling to achieve optimal oncolytic reovirus efficacy.


Sign in / Sign up

Export Citation Format

Share Document